ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 23, 2019

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2027

Conditions
Obstructive Sleep ApneaAlzheimer DiseaseVascular DementiaMild Cognitive ImpairmentParkinsons Disease With DementiaDementia With Lewy BodiesMixed Dementia
Interventions
DEVICE

In-laboratory polysomnography

Level 1 in-laboratory polysomnography for the detection of obstructive sleep apnea.

DEVICE

Home Sleep Apnea Test

Use of a home sleep apnea test that records respiratory effort, pulse, oxygen saturation and nasal flow, and reports apneas, hypopneas, flow limitation, snoring and blood oxygen saturation in order to detect obstructive sleep apnea.

Trial Locations (1)

M4N3M5

RECRUITING

Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors
collaborator

Unity Health Toronto

OTHER

lead

Sunnybrook Health Sciences Centre

OTHER